TMS Therapy, Esketamine & SPRAVATO

TMS therapy, Esketamine, and SPRAVATO are breakthrough treatments that have garnered significant attention for their potential to address treatment-resistant mental health conditions. However, despite their proven benefits, healthcare providers often face challenges in obtaining reimbursement for these services. The landscape of insurance coverage for these treatments can vary widely, with policies differing between payers and regions.

Schedule a Discussion

Professional Medical Billing Services for TMS Therapy, Esketamine & SPRAVATO

In recent years, advancements in medical science have led to innovative treatments for various mental health disorders, including Transcranial Magnetic Stimulation (TMS) therapy, Esketamine, and SPRAVATO. These treatments offer hope for patients struggling with conditions like depression, anxiety, and PTSD, but alongside their efficacy comes the complexity of reimbursement and medical billing. For healthcare providers offering these transformative therapies, navigating the intricacies of insurance billing and reimbursement can be daunting. This is where professional medical billing services play a crucial role.

Transcranial Magnetic Stimulation (TMS) Therapy Billing Guidelines

  • Transcranial Magnetic Stimulation (TMS) Therapy has emerged as a promising treatment option for individuals with depression who have not adequately responded to traditional antidepressant medications. This non-invasive procedure involves the use of magnetic fields to stimulate nerve cells in the brain, particularly in the prefrontal cortex.
  • CPT Codes: TMS Therapy is typically billed under Current Procedural Terminology (CPT) codes. The primary code used is 90867 for TMS therapy sessions administered in an office setting.
  • Documentation Requirements: Accurate documentation is essential for billing TMS Therapy. This includes the patient’s diagnosis, treatment plan, the number of pulses administered, and the duration of each session.
  • Coverage Verification: Prior to initiating TMS Therapy, it’s imperative to verify the patient’s insurance coverage. Some insurers may require pre-authorization or have specific criteria for coverage.

Esketamine Billing Guidelines

  • Esketamine, a derivative of ketamine, has garnered attention as a rapid-acting antidepressant for individuals with treatment-resistant depression. Administered nasally under medical supervision, esketamine therapy offers a novel approach to managing severe depression.
  • HCPCS Codes: Esketamine is billed using Healthcare Common Procedure Coding System (HCPCS) codes. The primary code for esketamine nasal spray is J3490, which is used for unclassified drugs.
  • Administration and Monitoring: In addition to the medication cost, billing should include charges for administration, monitoring, and any necessary medical supervision during and after the esketamine infusion.
  • Reimbursement Challenges: Reimbursement for esketamine therapy can vary widely among insurers. Understanding each payer’s policies and requirements is essential for accurate billing and reimbursement.
We are always available to answer any questions


Don’t let your practice be lost in the maze of claim rejections, non-pays, EOBs, and LCDs. Put an end to the insurance chase. Team up with our experts for outsourcing your medical billing.